drugset / Trial / NCT03816670

Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF

NCT03816670

Completed 113 enrolled University of Turin, Italy
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the number of retrieved oocytes in the late start CF-alfa (day 4) versus standard CF-alfa protocols (day 2) in patients undergoing IVF. The primary analysis will be also performed in specific subgroups of patients: expected poor-responders, expected normal responders and expected hyper-responders

Timeline

Start
2017-04-01
Primary completion
2018-04-30
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Corifollitropin alfa Protein / enzyme biologic

Indications